Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug
procurement, delivery and healthcare platform, today announced its engagement
of international investor relations specialists MZ Group (“MZ”) to expand its
comprehensive strategic investor relations and financial communications program
across all key markets. According to the update, MZ Group will work closely
with Trxade Group management in the development and implementation of a
comprehensive capital markets strategy designed to increase the Company’s
visibility throughout the investment community. “This is an exciting time for
Trxade Group, having achieved key growth milestones in 2019, positioning us for
a breakout year in 2020 as we continue to scale our proprietary platform,”
Trxade Group chairman and CEO Suren Ajjarapu said in the news release. “The
importance of our trading platform has been validated by the market, having
grown our footprint of registered independent pharmacy members to 40% in 2019
to over 12,100 locations nationwide. These pharmacies have seen purchasing
efficiencies on our platform before and during the COVID-19 pandemic, as we
uniquely positioned to supply COVID-19 test kits in time to make a difference
in the lives of their patients. Together with MZ Group, we will enhance our
investor communications and awareness efforts, while simultaneously working to
create sustainable value for our shareholders over the long-term.”
To view the full press release, visit http://ibn.fm/p2JQW
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASQAQ:
MEDS) is an integrated drug procurement, delivery and healthcare platform that
enables price transparency and increased profit margins to buyers and sellers
of pharmaceuticals, makes healthcare services affordable and accessible across
all 50 states, and steps in to meet today’s immediate demands. Founded in 2010,
Trxade Group is comprised of four synergistic operating platforms; the Trxade
B2B trading platform with 12,100 registered pharmacies, a licensed virtual
Wholesaler, affordable healthcare via its Bonum Health app or web-based
telehealth services, and same day or mail order pharmacy delivery capabilities
via its DelivMeds app featuring its extensive nationwide distribution network.
For additional information, please visit www.Trxade.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
